{"id":"W1753424155","doi":"","title":"Safety of biologic therapies--an update.","year":2005,"lang":"en","type":"article","venue":"PubMed","topic":"Rheumatoid Arthritis Research and Therapies","field":"Medicine","cited_by":86,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Toronto; Mount Sinai Hospital","funders":"","keywords":"Medicine; Adalimumab; Etanercept; Rheumatoid arthritis; Infliximab; Malignancy; Heart failure; Tumor necrosis factor alpha; Position paper; Biologic Agents; Quality of life (healthcare); Tumor necrosis factor α; Intensive care medicine; Internal medicine; Oncology; Physical therapy; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003674479,0.0008250842,0.001879649,0.001723092,0.0002978613,0.002060923,0.001107251,0.001755793,0.005995093],"category_scores_gemma":[0.007137377,0.0002126374,0.0008238181,0.002213193,0.0003759129,0.001960792,0.0004690375,0.001878069,0.003601225],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007484069,"about_ca_system_score_gemma":0.001351312,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.000930575,"about_ca_topic_score_gemma":0.002061425,"domain_scores_codex":[0.9979652,0.0004448233,0.0004781241,0.0001268422,0.0009176074,0.000067463],"domain_scores_gemma":[0.990128,0.004525322,0.001477796,0.0002429174,0.003295364,0.0003306983],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0002141887,0.00004720445,0.001721459,0.002800536,0.00009840073,0.0002507161,0.00003276602,0.0000873629,0.0002897904,0.0004180338,0.0549829,0.9390566],"study_design_scores_gemma":[0.0001504243,0.0007451609,0.01116083,0.006601275,0.000916734,0.008532044,0.0001492411,0.0003367421,0.001035403,0.001347459,0.9689807,0.00004406101],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.001256353,0.980355,0.0008436161,0.006550509,0.002649454,0.000022455,0.0003723156,0.00006758532,0.007882817],"genre_scores_gemma":[0.01423671,0.9640937,0.002504137,0.00678124,0.006762096,0.00005688255,0.001236018,0.00002362491,0.004305607],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005995093,"threshold_uncertainty_score":0.02005559,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.02510324623191532,"score_gpt":0.2634625084403715,"score_spread":0.2383592622084562,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}